Search

146 results for “review”

• Review ArticleOpen Access

  Rituximab, a Safer Option for Rheumatoid Arthritis: A Comparison of the Reported Adverse Events of Approved Monoclonal Antibodies

  Sweety Sharma, Somnath Basu, Ramesh K. Goyal, Parbhat K. Sahoo, Rajani Mathur

  Vol. 13 · Issue 4 · pp. 330–340

  https://doi.org/10.1177/0976500X231154743
  Full text ↗PDF

• Review ArticleOpen Access

  A Comparative Study of Chromium: Therapeutic Uses and Toxicological Effects on Human Health

  Anaiska Ray, Jayshri Sadashiv Jankar

  Vol. 13 · Issue 3 · pp. 239–245

  https://doi.org/10.1177/0976500X221128646
  Full text ↗PDF

• Review ArticleOpen Access

  Tapinarof: A Felicitous Discovery in Psoriasis Treatment

  Indumathi Prabath, Subhiksha Subramanian, Jamuna Rani

  Vol. 13 · Issue 3 · pp. 222–228

  https://doi.org/10.1177/0976500X221130851
  Full text ↗PDF

• Review ArticleOpen Access

  An Overview of the Extraarticular Involvement in Rheumatoid Arthritis and its Management

  Subham Das, Prasanta Padhan

  Vol. 8 · Issue 3 · pp. 81–86

  https://doi.org/10.4103/jpp.JPP_194_16
  Full text ↗PDF

• Review ArticleOpen Access

  Lesinurad: A significant advancement or just another addition to existing therapies of gout?

  Ajay Gupta, Pramod Kumar Sharma, Arup Kumar Misra, Surjit Singh

  Vol. 7 · Issue 4 · pp. 155–158

  https://doi.org/10.4103/0976-500X.195897
  Full text ↗PDF

• Review ArticleOpen Access

  Inhaled insulin: A “puff” than a “shot” before meals

  Dick B. S. Brashier, Anjan Khadka, Tejus Anantharamu, Ashok Kumar Sharma, A. K. Gupta

  Vol. 6 · Issue 3 · pp. 126–129

  https://doi.org/10.4103/0976-500X.162013
  Full text ↗PDF

• Review ArticleOpen Access

  Riociguat: Something new in pulmonary hypertension therapeutics?

  Elangovan Shanmugam, Amrita Jena, Melvin George

  Vol. 6 · Issue 1 · pp. 3–6

  https://doi.org/10.4103/0976-500X.149132
  Full text ↗PDF

• Review ArticleOpen Access

  Efficacy of novel monoclonal antibody belimumab in the treatment of lupus nephritis

  Marianne Frieri, William Heuser, Joshua Bliss

  Vol. 6 · Issue 2 · pp. 71–76

  https://doi.org/10.4103/0976-500X.155482
  Full text ↗PDF

• EditorialOpen Access

  Push, promote or educate…musings of a pharmacologist on drug promotion

  Chanolean Shashindran

  Vol. 5 · Issue 4 · pp. 225–226

  https://doi.org/10.4103/0976-500X.142427
  Full text ↗PDF

• Review ArticleOpen Access

  Metabolic syndrome in schizophrenia: Differences between antipsychotic‑naïve and treated patients

  Rakesh K. Chadda, Prashanth Ramshankar, Koushik S. Deb, Mamta Sood

  Vol. 4 · Issue 3 · pp. 176–176

  https://doi.org/10.4103/0976-500X.114596
  Full text ↗PDF

• Case ReviewOpen Access

  Corticosteroid-related central nervous system side effects

  Miriam Ciriaco, Pasquale Ventrice, Gaetano Russo, Maria Scicchitano, Giovanni Mazzitello, Francesca Scicchitano, Emilio Russo

  Vol. 4 · Issue Supplement 1 · pp. S94–S95

  https://doi.org/10.4103/0976-500X.120975
  Full text ↗PDF

• Review ArticleOpen Access

  Clinical and economic burden of adverse drug reactions

  Janet Sultana, Paola Cutroneo, Gianluca Trifirò

  Vol. 4 · Issue 1 · pp. S73–S74

  https://doi.org/10.4103/0976-500X.120957
  Full text ↗PDF

• Review ArticleOpen Access

  Pharmacovigilance in Italy: An overview

  Carmela Mazzitello, Stefania Esposito, Adele E. De Francesco, Annalisa Capuano, Emilio Russo, Giovambattista De Sarro

  Vol. 4 · Issue Supplement 1 · pp. S20–S21

  https://doi.org/10.4103/0976-500X.120942
  Full text ↗PDF

• Mini ReviewOpen Access

  Anti-vascular endothelial growth factor drugs safety and efficacy in ophthalmic diseases

  Pasquale Ventrice, Christian Leporini, Jose’ Francisco Aloe, Ettore Greco, Giacomo Leuzzi, Giuseppina Marrazzo, Giovanni Battista Scorcia, Donatella Bruzzichesi, Varano Nicola, Vincenzo Scorcia

  Vol. 4 · Issue Supplement 1 · pp. S38–S39

  https://doi.org/10.4103/0976-500X.120947
  Full text ↗PDF

• Case ReviewOpen Access

  Nexavar®-related adverse reactions: Calabrian (Italy) experience for sorafenib exposition in 2012

  Felisa Cilurzo, Orietta Staltari, Marinella Patanè, Michele Ammendola, Caterina Garaffo, Eugenio Donato Paola

  Vol. 4 · Issue 1 · pp. S86–S86

  https://doi.org/10.4103/0976-500X.120971
  Full text ↗PDF

• Case ReviewOpen Access

  The safety of ketoprofen in different ages

  Claudia Carbone, Pierandrea Rende, Pasquale Comberiati, Domenico Carnovale, Maria Mammì, Giovambattista De Sarro

  Vol. 4 · Issue Supplement 1 · pp. S99–S100

  https://doi.org/10.4103/0976-500X.120967
  Full text ↗PDF

• Mini ReviewOpen Access

  Iptakalim: A novel multi-utility potassium channel opener

  (Kir6.1s) (Kir6.1s), regulatory sulphonylurea subunits (SUR).[3] IPT shows high selectivity for cardiac KATP (SUR2A/Kir6.2), vascular KATP (SUR2B/Kir6.1 or SUR6B/Kir6.2). Because

  Vol. 3 · Issue 1 · pp. 12–14

  https://doi.org/10.4103/0976-500X.92495
  Full text ↗PDF

• Review ArticleOpen Access

  MicroRNAs as newer therapeutic targets: A big hope from a tiny player

  Hardik S. Ghelani, Manish A. Rachchh, Rina H. Gokani

  Vol. 3 · Issue 3 · pp. 217–227

  https://doi.org/10.4103/0976-500X.99416
  Full text ↗PDF

• Review ArticleOpen Access

  Epilepsy: Novel therapeutic targets

  Ashish P. Anovadiya, Jayesh J. Sanmukhani, C. B. Tripathi

  Vol. 3 · Issue 2 · pp. 112–117

  https://doi.org/10.4103/0976-500X.95505
  Full text ↗PDF

• Mini ReviewOpen Access

  Ulipristal acetate, a progesterone receptor modulator for emergency contraception

  Shilpa P. Jadav, Dinesh M. Parmar

  Vol. 3 · Issue 2 · pp. 109–111

  https://doi.org/10.4103/0976-500X.95504
  Full text ↗PDF